Sarveshwar Foods (SARVESHWAR)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 15.82% and profit growth of 30.27% show recent momentum.
• Piotroski F-Score of 7/9 indicates solid financial health and improving fundamentals.
• Debt/Equity of 0.57 is moderate, and ROCE of 13.14% reflects decent operating efficiency.
• Promoter holding of 40.97% provides reasonable alignment with minority shareholders.

Concerns

• ROE of only 4.92% is weak, especially against P/B of 2.17.
• Latest quarter net profit of ₹9 Cr on sales of ₹327 Cr implies a razor-thin margin vulnerable to cost or price shocks.
• Zero dividend yield means shareholders must rely entirely on future capital gains.
• Commodity agricultural products typically lack pricing power and a durable competitive moat.

AI Analysis

When I look at Sarveshwar Foods, I start with return on tangible capital. At 4.92% ROE, this business barely earns its keep; a shareholder would earn little more than a fixed deposit before considering leverage. ROCE of 13.14% is respectable, but debt-to-equity of 0.57 means some of that return is juiced by borrowing. My Graham instincts demand a margin of safety: book value ₹1.86 versus price ₹4.04 translates to P/B 2.17. For such low returns, that multiple is not cheap. The P/E of 14.25 is not demanding, but it is justified only if growth is durable. Profit growth of 30.27% and PEG of 0.62 look attractive on the surface, but net profit in latest quarter is ₹9 Cr on sales of ₹327 Cr — a razor-thin margin of under 3%. This is a commodity business in Other Agricultural Products; without pricing power, a moat is hard to find. Promoter holding of 40.97% is acceptable, and Piotroski F-score 7/9 suggests the balance sheet is improving. Still, dividend yield is zero, so any return depends entirely on capital gains. I would not call this a wonderful business. It may be a cyclical with earnings leveraged to food commodity cycles. If prices rise, margins could expand; if they reverse, the low margin kills profits. At ₹4.04, near the lower end of 52-week range ₹2.50–₹8.45, there is some optimism built into financials, but the returns do not yet support a Buffett-type purchase. I want either a stronger franchise or a much lower price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer